Agitation in Alzheimer’s Disease: What We Know and Where We’re Going
Alzheimer’s disease-associated behavioral symptoms such as agitation are particularly distressful and burdensome for patients and care partners, and they are…
Alzheimer’s disease-associated behavioral symptoms such as agitation are particularly distressful and burdensome for patients and care partners, and they are…
Atlas Venture partner and LifeSciVC author Bruce Booth shares his 2024 Year in Review. Recorded on November 7, 2024. 00:00 Introduction 01:53 Biopharma Innov…
Background and ObjectivesThe rs763361 nonsynonymous variant in the CD226 gene, which results in a glycine-to-serine substitution at position 307 of the CD226 protein, has been…
Welcome! You are invited to join a meeting: Emory Stroke Fellowship Virtual Open House. After registering, you will receive a confirmation email about joining the…
Alexander A. Bruckhaus, Tuba Asifriyaz, Kseniia Kriukova, Terence J. O’Brien, Denes V. Agoston, Richard J. Staba, Nigel C. Jones, Solomon L. Moshé, Aristea S. Galanopoulou,…
Moderator: J. Helen Cross (United Kingdom) Speakers: Lara Jehi (United States), Kees Braun (Netherlands) and Manjari Tripathi (India) Please note that the companies have had…
Reetta Kälviäinen, Zakarya Hadj-Allal, Jarkko Kirjavainen, Reina Roivainen, Tarja Linnankivi, Jukka Peltola, Kai Eriksson, Salla Lamusuo, Tuire Lähdesmäki, Johanna Annunen, Päivi Vieira, Virpi Tarkiainen, Leena…
Please check here regularly as we continue to provide updates and relevant information about the congress. If you have any queries, please contact i e…
Corinna Elling-Audersch introduces the EULAR Stene Prize 2025 Topic: “Growing up with an RMD – learning, transitioning from paediatrics and the impacts on ch…
Nature Neuroscience – Tyrosine kinase 2 (TYK2) critically regulates tau levels and aggregation by phosphorylating tau’s tyrosine 29. Partial inhibition of TYK2 mitigates tau pathologies…